肥胖对膝盖关节整形术后日常活动的影响
Kevin A Wu1, David N Kugelman2, Sharrieff N Shah3
1Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
The Journal of arthroplasty
|November 2, 2025
概括
较高的体重指数 (BMI) 与全膝关节整形术 (TKA) 后的日常活动减少有关. 然而,TKA后活动水平的改善在所有BMI组中都是相似的,这表明量身定制的计划可以优化恢复.
科学领域:
- 整形外科 整形外科 整形外科
- 生物医学工程 生物医学工程
- 康复科学 康复科学 康复科学
背景情况:
- 肥胖是膝关节骨关节炎的重要危险因素,通常需要全膝关节关节整形术 (TKA).
- 身体质量指数 (BMI) 对TKA后功能恢复和日常活动的影响需要进一步调查.
研究的目的:
- 调查BMI对手术后每日活动和TKA患者的步态指标的影响.
- 为了比较TKA后的不同BMI类别的活动水平和功能结果.
主要方法:
- 一项前性队列研究,涉及152名接受单边TKA的患者,按BMI分类 (正常体重,超重,肥胖,致病肥胖).
- 客观活动指标 (步数,站立时间,步行速度,稳定性,6分钟步行测试) 在手术前和术后最长12个月收集.
- 进行了多变量回归分析,对年龄和性别进行控制.
主要成果:
- 与正常体重患者相比,患有致病性肥胖症的患者的术前步数显著降低.
- 虽然所有BMI组都显示了手术后的改善,但患有致病性肥胖症的患者在12个月后保持了较低的活动水平.
- 较高的BMI与12个月后手术后活动减少有关,尽管从基线的改善在各组之间是可比的.
结论:
- 增加的BMI与TKA后的日常活动减少有关.
- 在TKA后活动的相对改善在BMI类别中是一致的.
- 建议进行预康复和个性化康复计划,以增强肥胖TKA患者的康复和活动.
更多相关视频
相关概念视频
01:23Peripheral Artery Disease V: Postoperative Nursing Management
365
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
365
01:21Drug Dosing: Obese Patients
216
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
216
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
233
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
233
01:24Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
164
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
164